Targeted Therapies in Oncology
December I 2025
Volume: 14
Issue: 15
November 2025
Volume: 14
Issue: 14
October 2025
Volume: 14
Issue: 13
September II 2025
Volume: 14
Issue: 12
September I 2025
Volume: 14
Issue: 11
August 2025
Volume: 14
Issue: 10
July 2025
Volume: 14
Issue: 9
June II 2025
Volume: 14
Issue: 8
June I 2025
Volume: 14
Issue: 7
May I 2025
Volume: 14
Issue: 6
April I 2025
Volume: 14
Issue: 5
March II 2025
Volume: 14
Issue: 4
March I 2025
Volume: 14
Issue: 3
February I, 2025
Volume: 14
Issue: 2
January I 2025
Volume: 14
Issue: 1
December II, 2024
Volume: 13
Issue: 16
December I, 2024
Volume: 13
Issue: 15
November I, 2024
Volume: 13
Issue: 14
October I, 2024
Volume: 13
Issue: 13
September II, 2024
Volume: 13
Issue: 12
September I, 2024
Volume: 13
Issue: 11
August I, 2024
Volume: 13
Issue: 10
July I, 2024
Volume: 13
Issue: 9
June 02, 2024
Volume: 13
Issue: 8
June I, 2024
Volume: 13
Issue: 7
May I, 2024
Volume: 13
Issue: 6
April I, 2024
Volume: 13
Issue: 5
March II, 2024
Volume: 13
Issue: 4
March I, 2024
Volume: 13
Issue: 3
February I, 2024
Volume: 13
Issue: 2
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
3
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
